Reducing Hereditary Cancer Act of 2022
Legislative Progress
Introduced
February 16, 2022
Latest Action
February 16, 2022
Primary Sponsor
Lisa MurkowskiRepublican(AK)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Reducing Hereditary Cancer Act of 2022 This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2022 · fourth_quarter · Medicare/Medicaid
HR 315 - Medicare Sequester Moratorium Act - relief from Medicare sequester HR 1332/ S 368 -Telehealth Modernization Act - permanent repeal of Medicare geographic and originating site restrictions HR 1946/S 1873- Multi Cancer Early Detection Coverage and Screening Act - provide for Medicare coverage of multi-cancer early detection screening tests HR 1577/S 596 - Treat and Reduce Obesity Act of 2021 - expands Medicare coverage of intensive behavioral therapy for obesity HR 2347/S 2691 - Strengthening the Vaccines for Children Program Act of 2021 - ensure adequate access to vaccines under the Medicaid program and the Vaccines for Children program S 1287 - REFUND Act of 2021 - provide refunds for certain single dose vial drugs HR 2903/S 1512- CONNECT for Health Act of 2021 - expand access to telehealth services HR 3173/S 3018- Improving Seniors Timely Access to Care Act of 2021- establishes several requirements and standards relating to prior authorization processes under Medicare Advantage plans HR 3447 - Permanency for Audio-Only Telehealth Act- expand accessibility to certain telehealth services under Medicare HR 4110/S 3656- Reducing Hereditary Cancer Act- provide hereditary cancer genetic testing HR 3089/S 1544- Accelerating Kids' Access to Care Act- streamline enrollment under the Medicaid program of certain providers across State lines HR 1978/S 912- Protecting Seniors Through Immunization Act of 2021- improve Medicare coverage of vaccinations HR 7995- GOLD CARD Act of 2022- exempts qualifying physicians from prior authorization requirements in Medicare Advantage plans HR 5377- Cancer Patient Equity Act of 2021- provides coverage of cancer diagnostic and laboratory tests under Medicare, Medicaid, and CHIP Drug pricing- Inflation Reduction Act HR 8800- Supporting Medicare Providers Act of 2022- Medicare reimbursement HR 8487- Improving Seniors Timely Access to Care Act of 2022- establishes several requirements and standards relating to prior authorization processes under Medicare Advantage plans Omnibus: PAYGO, sequestration, HR 8800, APM bonus HR 2410/S 5117- Medicare & You Handbook Improvement Act of 2021- requires the inclusion of information on prior authorization requirements and other utilization management techniques in the Medicare & You annual notice.
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medical/Disease Research/Clinical Labs
cancer research at DoD and NIH HR 8236/S no bill #, FY23 Defense Appropriations Act Peer-Reviewed Pancreatic Cancer Research Program HR 8295/S no bill #, FY23 Labor-HHS-Education Act, NIH research on pancreatic cancer HR 4110/S 3656, Reducing Hereditary Cancer Act HR 2617/PL 117-328, Consolidated Appropriations Act, fiscal year 2023, DoD Pancreatic Cancer Research Program and NIH pancreatic cancer research
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medical/Disease Research/Clinical Labs
cancer research at DoD and NIH HR 8236/S no bill #, FY23 Defense Appropriations Act Peer-Reviewed Pancreatic Cancer Research Program HR 8295/S no bill #, FY23 Labor-HHS-Education Act, NIH research on pancreatic cancer HR 4110/S 3656, Reducing Hereditary Cancer Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2022 · third_quarter · Medicare/Medicaid
HR 315 - Medicare Sequester Moratorium Act - relief from Medicare sequester HR 1332/ S 368 -Telehealth Modernization Act - permanent repeal of Medicare geographic and originating site restrictions HR 1946/S 1873- Multi Cancer Early Detection Coverage and Screening Act - provide for Medicare coverage of multi-cancer early detection screening tests HR 1577/S 596 - Treat and Reduce Obesity Act of 2021 - expands Medicare coverage of intensive behavioral therapy for obesity HR 2347/S 2691 - Strengthening the Vaccines for Children Program Act of 2021 - ensure adequate access to vaccines under the Medicaid program and the Vaccines for Children program S 1287 - REFUND Act of 2021 - provide refunds for certain single dose vial drugs HR 2903/S 1512- CONNECT for Health Act of 2021 - expand access to telehealth services HR 3173/S 3018- Improving Seniors Timely Access to Care Act of 2021- stablishes several requirements and standards relating to prior authorization processes under Medicare Advantage plans HR 3447 - Permanency for Audio-Only Telehealth Act- expand accessibility to certain telehealth services under Medicare HR 4110/S 3656- Reducing Hereditary Cancer Act- provide hereditary cancer genetic testing HR 3089/S 1544- Accelerating Kids' Access to Care Act- streamline enrollment under the Medicaid program of certain providers across State lines HR 1978/S 912- Protecting Seniors Through Immunization Act of 2021- improve Medicare coverage of vaccinations HR 7995- GOLD CARD Act of 2022- exempts qualifying physicians from prior authorization requirements in Medicare Advantage plans HR 5377- Cancer Patient Equity Act of 2021- provides coverage of cancer diagnostic and laboratory tests under Medicare, Medicaid, and CHIP Drug pricing- Inflation Reduction Act HR 8800- Supporting Medicare Providers Act of 2022- Medicare reimbursement HR 8487- Improving Seniors Timely Access to Care Act of 2022- establishes several requirements and standards relating to prior authorization processes under Medicare Advantage plans
Client expense: $125,406 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
HR 315 - Medicare Sequester Moratorium Act - relief from Medicare sequester HR 1332/ S 368 -Telehealth Modernization Act - permanent repeal of Medicare geographic and originating site restrictions HR 1946/S 1873- Multi Cancer Early Detection Coverage and Screening Act - provide for Medicare coverage of multi-cancer early detection screening tests HR 1577/S 596 - Treat and Reduce Obesity Act of 2021 - expands Medicare coverage of intensive behavioral therapy for obesity HR 2347/S 2691 - Strengthening the Vaccines for Children Program Act of 2021 - ensure adequate access to vaccines under the Medicaid program and the Vaccines for Children program S 1287 - REFUND Act of 2021 - provide refunds for certain single dose vial drugs HR 2903/S 1512- CONNECT for Health Act of 2021 - expand access to telehealth services HR 3173/S 3018- Improving Seniors Timely Access to Care Act of 2021- stablishes several requirements and standards relating to prior authorization processes under Medicare Advantage plans HR 3447 - Permanency for Audio-Only Telehealth Act- expand accessibility to certain telehealth services under Medicare HR 4110/S 3656- Reducing Hereditary Cancer Act- provide hereditary cancer genetic testing HR 3089/S 1544- Accelerating Kids' Access to Care Act- streamline enrollment under the Medicaid program of certain providers across State lines HR 1978/S 912- Protecting Seniors Through Immunization Act of 2021- improve Medicare coverage of vaccinations HR 7995- GOLD CARD Act of 2022- exempts qualifying physicians from prior authorization requirements in Medicare Advantage plans HR 5377- Cancer Patient Equity Act of 2021- provides coverage of cancer diagnostic and laboratory tests under Medicare, Medicaid, and CHIP Drug pricing
Client expense: $155,610 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medicare/Medicaid
HR 315 - Medicare Sequester Moratorium Act - relief from Medicare sequester HR 1332/ S 368 -Telehealth Modernization Act - permanent repeal of Medicare geographic and originating site restrictions HR 1946/S 1873- Multi Cancer Early Detection Coverage and Screening Act - provide for Medicare coverage of multi-cancer early detection screening tests HR 1577/S 596 - Treat and Reduce Obesity Act of 2021 - expands Medicare coverage of intensive behavioral therapy for obesity HR 2347/S 2691 - Strengthening the Vaccines for Children Program Act of 2021 - ensure adequate access to vaccines under the Medicaid program and the Vaccines for Children program S 1287 - REFUND Act of 2021 - provide refunds for certain single dose vial drugs HR 2903/S 1512- CONNECT for Health Act of 2021 - expand access to telehealth services HR 3173/S 3018- Improving Seniors Timely Access to Care Act of 2021- stablishes several requirements and standards relating to prior authorization processes under Medicare Advantage plans HR 3447 - Permanency for Audio-Only Telehealth Act- expand accessibility to certain telehealth services under Medicare HR 4110/S 3656- Reducing Hereditary Cancer Act- provide hereditary cancer genetic testing HR 3089/S 1544- Accelerating Kids' Access to Care Act- streamline enrollment under the Medicaid program of certain providers across State lines HR 1978/S 912- Protecting Seniors Through Immunization Act of 2021- improve Medicare coverage of vaccinations
Client expense: $213,980 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE